Monitoring Kidney Function in Neuroendocrine Tumor Patients Treated with ⁹⁰Y-DOTATOC: Associations with Risk Factors

E-ISSN： 1874-4729|8|1|49-55

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.8, Iss.1, 2015-05, pp. : 49-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standardization of Procedures for the Preparation of ¹⁷⁷Lu- and ⁹⁰Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation

Current Radiopharmaceuticals, Vol. 8, Iss. 1, 2015-05 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite

¹⁷⁷Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 85-93

Bentham Science Publishers

Access to resources Recommend Favorite

109Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a Potential Agent for Targeted Tumor Therapy

Current Radiopharmaceuticals, Vol. 5, Iss. 4, 2012-10 ,pp. : 340-347

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of ¹⁷⁷Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 64-70

Bentham Science Publishers

Access to resources Recommend Favorite

Visualising Neuroinflammation in Post-Stroke Patients: A Comparative PET Study with the TSPO Molecular Imaging Biomarkers [11C]PK11195 and [11C]vinpocetine

Current Radiopharmaceuticals, Vol. 5, Iss. 1, 2012-01 ,pp. : 19-28

Bentham Science Publishers

Access to resources Recommend Favorite